CRP and COVID-19: Anti-SARS-CoV-2 IgG antibodies were detected in 49 out of 56 tested patients (87.5%), and this seroconversion was statistically more common in patients with a more severe course of COVID-19 (as indicated by abnormal chest X-ray results and higher CRP and D-dimer concentrations).